House Michael G, Cameron John L, Schulick Richard D, Campbell Kurt A, Sauter Patricia K, Coleman Joann, Lillemoe Keith D, Yeo Charles J
Department of Surgery, Johns Hopkins Medical Institutions, Baltimore, MD 21287, USA.
Ann Surg. 2006 May;243(5):571-6; discussion 576-8. doi: 10.1097/01.sla.0000216285.07069.fc.
This single-institution review examined the incidence of biliary stricture formation after pancreaticoduodenectomy (PD) for benign and malignant periampullary disease.
The incidence and course of stricture of the hepaticojejunostomy have not been documented after PD.
Between January 1995 and April 2003, 1595 patients underwent PD for periampullary disease (392 benign, 1203 malignant). A retrospective analysis of a prospectively collected database was performed to determine the incidence of biliary stricture after PD.
Forty-two of the 1595 patients (2.6%) who underwent PD developed postoperative jaundice secondary to a stricture of the biliary-enteric anastomosis. There was no difference in the incidence of biliary strictures after resection for benign (n = 10, 2.6%) or malignant disease (n = 32, 2.6%). The median time to stricture formation resulting in jaundice was 13 months (range, 1-106 months) and was similar for patients with benign and malignant disease. Preoperative jaundice did not protect against biliary stricture formation. By univariate analysis, biliary strictures were associated with preoperative percutaneous biliary drainage (odds ratio [OR] = 2.11, P = 0.02) and postoperative biliary stenting (OR = 2.11, P = 0.013). Postoperative chemoradiotherapy in patients with malignant disease was not associated with stricture formation. All strictures were initially managed with percutaneous biliary balloon dilatation and stenting, and only 2 patients required redo hepaticojejunostomy. Recurrent neoplastic disease was discovered in only 3 of the 32 patients (9%) with malignant disease. All 3 of these patients had cholangiocarcinoma as their initial diagnosis.
Biliary stricture formation is an infrequent complication after PD and can be managed successfully with percutaneous biliary dilatation and short-term stenting in most patients. The only significant univariate predictors for biliary stricture formation were preoperative and postoperative percutaneous biliary drainage. The development of a biliary stricture in patients who have undergone PD for malignant disease is usually benign and should not be automatically attributed to anastomotic tumor recurrence.
本单机构回顾性研究探讨了因良性和恶性壶腹周围疾病行胰十二指肠切除术(PD)后胆管狭窄形成的发生率。
PD术后肝空肠吻合口狭窄的发生率及病程尚无文献记载。
1995年1月至2003年4月,1595例患者因壶腹周围疾病接受了PD手术(392例良性疾病,1203例恶性疾病)。对前瞻性收集的数据库进行回顾性分析,以确定PD术后胆管狭窄的发生率。
1595例行PD手术的患者中,42例(2.6%)因胆肠吻合口狭窄出现术后黄疸。良性疾病(n = 10,2.6%)或恶性疾病(n = 32,2.6%)切除术后胆管狭窄的发生率无差异。导致黄疸的狭窄形成的中位时间为13个月(范围1 - 106个月),良性和恶性疾病患者相似。术前黄疸并不能预防胆管狭窄的形成。单因素分析显示,胆管狭窄与术前经皮胆道引流相关(比值比[OR]=2.11,P = 0.02)及术后胆道支架置入相关(OR = 2.11,P = 0.013)。恶性疾病患者术后放化疗与狭窄形成无关。所有狭窄最初均采用经皮胆道球囊扩张及支架置入治疗,仅2例患者需要再次行肝空肠吻合术。32例恶性疾病患者中仅3例(9%)发现肿瘤复发。这3例患者均以胆管癌为初始诊断。
胆管狭窄形成是PD术后少见的并发症,大多数患者通过经皮胆道扩张及短期支架置入可成功处理。胆管狭窄形成的唯一显著单因素预测因素是术前及术后经皮胆道引流。因恶性疾病行PD手术的患者出现胆管狭窄通常为良性,不应自动归因于吻合口肿瘤复发。